This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
12 - 14 Nov 2024
Hamburg Congress CentreHamburg, Germany

Christian Heinis, Ph.D.
Associate Professor at Ecole PolyTechnique Federale de Lausanne
Speaker

Profile

Christian Heinis studied chemistry/biochemistry at the ETH Zurich. After a PhD in the research group of Prof. Dr. Dario Neri at ETH Zurich, he did two post-docs, the first one with Prof. Dr. Kai Johnsson at the EPFL in Lausanne and the second one with Sir Gregory Winter at the LMB-MRC in Cambridge, UK. In 2008 he started as Assistant Professor at EPFL (supported with an SNSF professorship) and was promoted in 2015 to Associate Professor. Christian Heinis is co-founder of the companies Bicycle Therapeutics and Orbis Medicines.

Agenda Sessions

  • Development of Cyclic Peptide Ligands Against Intracellular Targets

    16:00